ClearPoint Neuro Q3 2026 Results: Net Loss of $7.46M, Loss Widens
ClearPoint Neuro, Inc. reported total revenue of $12.1 million for the third quarter of 2026, a 36% increase compared to the same period in 2025, driven primarily by product revenue growth. Despite the revenue increase, the company reported a net loss of $7.5 million for the quarter as operating expenses rose to $13.4 million, largely due to higher sales and marketing costs.
- Key figure
- Net loss $7.46M